ABSTRACT
The motor thalamus plays a crucial role in the integration and modulation of sensorimotor information and projects to the primary motor cortex. While voltage power spectral changes in the motor cortex with movement have been well-characterized, the corresponding activity in the motor thalamus, particularly broadband (sometimes referred to as high gamma) power, remains unclear. The present study aims to characterize spectral changes in the motor thalamus during hand movements of 15 subjects undergoing awake deep brain stimulation surgery targeting the ventral intermediate (VIM) nucleus of the thalamus for disabling tremor. We analyzed power changes in subject-specific low frequency oscillations (<30 Hz) and broadband power (captured in 65-115 Hz band) of serial field potential recordings. Consistent with previous studies, we found widespread decreases in low-frequency oscillations with movement. Importantly, in most subjects we also observed a significant increase in broadband power, primarily in the inferior recording sites corresponding with estimated VIM region. One subject also performed an imagined movement task during which low frequency oscillatory power was suppressed. These electrophysiologic changes may be leveraged as biomarkers for thalamic functional mapping, DBS targeting, and closed loop applications.
NEW & NOTEWORTHY We studied movement-associated spectral changes in the human motor thalamus of subjects undergoing awake deep brain stimulation surgery. We observed focal increases in broadband power in the motor thalamus with movement. This biomarker may be used as a tool for intraoperative functional mapping, DBS targeting, and closed-loop device control.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by: The Foundation for OCD research (KJM), MN partnership grant for biotechnology and medical genomics, (MNP#21.42; KJM & BTK), Fay/Frank Seed Grant (KJM), Brain Research Foundation (KJM), NIH-NCATS CTSA KL2 (TR002379; KJM), and NIH U01-NS128612 (KJM).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Mayo Clinic IRB has approved this research.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data necessary to interpret, verify, and extend the research will be anonymized and made publicly available with the final version of this article. A README document will be included detailing data variables. Code used to perform analyses and reproduce the illustrations will also be included.
